Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGi
| Image |  |
|---|---|
| Description | scientific article published on 16 January 2020 |
| Author/s |
author: João Pedro Ferreira Arantxa Gonzalez |
| Publication date | January 16, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |